NCT05154877View on ClinicalTrials.gov

Evaluation of a New Generation of PET-CT OMNI

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

May 30, 2022

Primary Completion Date

August 30, 2022

Study Completion Date

December 18, 2023

Conditions
Oncology
Interventions
DEVICE

OMNI PET/CT Scan

The subject will undergo two PET/CT scans: one on the standard of care scanner and one on the OMNI scanner.

Trial Locations (1)

Unknown

Institut Claudius Regaud, Toulouse

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
collaborator

Institut Claudius Regaud

OTHER

lead

GE Healthcare

INDUSTRY

NCT05154877 - Evaluation of a New Generation of PET-CT OMNI | Biotech Hunter | Biotech Hunter